Search

Your search keyword '"Breast Cancer Prevention Trial"' showing total 200 results

Search Constraints

Start Over You searched for: Descriptor "Breast Cancer Prevention Trial" Remove constraint Descriptor: "Breast Cancer Prevention Trial" Topic oncology Remove constraint Topic: oncology
200 results on '"Breast Cancer Prevention Trial"'

Search Results

1. Arm Morbidity After Local Therapy for Young Breast Cancer Patients

2. Abstract P6-13-06: Estrogen-based hormone replacement [HRT] therapy is substantially more effective than tamoxifen in reducing breast cancer mortality and breast cancer case fatality ratio: Emergence of a new paradigm

Catalog

Books, media, physical & digital resources

3. Psychometric Evaluation of the Chinese Breast Cancer Prevention Trial Symptom Scale

4. Disparities in the survivorship experience among Latina survivors of breast cancer

5. Abstract P5-18-01: Extended continuous vs intermittent adjuvant letrozole in postmenopausal women with lymph node-positive, early breast cancer (IBCSG 37-05/BIG 1-07 SOLE): Impact on patient-reported symptoms and quality of life

6. Abstract P5-13-02: Chemoprevention utilization in patients with a history of atypical hyperplasia, atypical lobular hyperplasia, or lobular carcinoma in-situ: A retrospective chart review of patients diagnosed at an urban hospital with a large minority patient population

7. Body Composition and Metabolomics in the Alberta Physical Activity and Breast Cancer Prevention Trial (OR09-02-19)

8. The Relationship Between Insomnia and Cognitive Impairment in Breast Cancer Survivors

9. Impact of aerobic exercise on levels of IL-4 and IL-10: results from two randomized intervention trials

10. Five year letrozole versus placebo in BRCA1/2 germline mutations carriers: Final results of LIBER, a double-blind randomized phase III breast cancer prevention trial

11. Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women

12. Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)

13. Problems of Breast Cancer Survivors Living in an Urban Area of Nepal

14. Abstract S3-07: 16 year long-term follow-up of the IBIS-I breast cancer prevention trial

15. Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial

16. Precancer Atlas to Drive Precision Prevention Trials

17. Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

18. Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial

19. Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study

20. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs

21. Towards Prevention of Breast Cancer: What Are the Clinical Challenges?

22. Tamoxifen for early breast cancer: an overview of the randomised trials

23. Abstract ES2-3: Managing increased breast cancer risk based on high and moderate penetrance gene mutations

24. Body Mass Index and the Risk for Developing Invasive Breast Cancer among High-Risk Women in NSABP P-1 and STAR Breast Cancer Prevention Trials

25. Cigarette Smoking, Obesity, Physical Activity, and Alcohol Use As Predictors of Chemoprevention Adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial

26. Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women

27. Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer

28. Abstract P5-09-01: Improving Informed Consent: Evaluating the First Decision Aid in a Clinical Trial Setting (IBIS-II Breast Cancer Prevention Trial)

29. Carcinoma In Situ Outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials

30. Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy

31. Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer

32. Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity

33. Inference of Tamoxifen's Effects on Prevention of Breast Cancer From a Randomized Controlled Trial

34. Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women

36. The National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: An International Breast Cancer Prevention Trial

37. Synthetic retinoid fenretinide in breast cancer chemoprevention

38. Twenty-Year Follow-up of the Royal Marsden Randomized, Double-Blinded Tamoxifen Breast Cancer Prevention Trial

39. Breast cancer risk reduction therapy: the low-hanging fruit

40. Recent Results from Clinical Trials Using SERMs to Reduce the Risk of Breast Cancer

41. Raloxifene and the prevention of breast cancer

42. Predicting Compliance in a Breast Cancer Prevention Trial

43. Chemoprevention of Breast Cancer in Postmenopausal Women

44. Effect of Factor V Leiden and Prothrombin G20210→A Mutations on Thromboembolic Risk in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial

45. Physical and Emotional Health Effects and Social Consequences After Participation in a Low-Fat, High-Carbohydrate Dietary Trial for More Than 5 Years

46. Clinical trials with retinoids for breast cancer chemoprevention

47. Benefit/Risk Assessment of SERM Therapy

48. The Breast Cancer Continuum

49. Breast Cancer Prevention with Selective Estrogen Receptor Modulators

50. The BCPT Symptom Scales: A Measure of Physical Symptoms for Women Diagnosed With or at Risk for Breast Cancer